No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio
CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)
CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ
Awakn Life Sciences Discusses Filing of Financial Statements
Canadian Securities Exchange Reports February 2024 Performance Figures